glp 1 agonist drugs mechanism of action Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review Mechanisms of action of GLP-1RA.
Description
A growing body of work suggests GLP-1 drugs act on platelets, immune cells, and vascular cells to protect against atherosclerosis independently of their effects on glycemia, appetite, and weight
doi: 10.1016/S2468-1253(17)30285-6
Findings are preliminary, and more research is needed to understand this risk
FDA, the laboratory contributes to research efforts that bridge academic investigation and regulatory science
In comes the SUSTAIN-7 trial
